 | Up a level |
Willers, C Corin; Frauchiger, Bettina S; Stranzinger, Enno; Bauman, Grzegorz; Moeller, Alexander; Jung, Andreas; Hector, Andreas; Regamey, Nicolas; Zanolari, Maura; Mueller-Suter, Dominik; Lioba Kuhn, Alena; Blanchon, Sylvain; Rochat, Isabelle; Latzin, Philipp; Ramsey, Kathryn A (2022). Feasibility of unsedated lung MRI in young children with cystic fibrosis. The European respiratory journal, 60(5) European Respiratory Society 10.1183/13993003.03112-2021
Kormann, Michael S D; Dewerth, Alexander; Eichner, Felizitas; Baskaran, Praveen; Hector, Andreas; Regamey, Nicolas; Hartl, Dominik; Handgretinger, Rupert; Antony, Justin S (2017). Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity. PLoS ONE, 12(8), e0183526. Public Library of Science 10.1371/journal.pone.0183526
Hector, Andreas; Kormann, Michael S D; Mack, Ines; Latzin, Philipp; Casaulta, Carmen; Kieninger, Elisabeth; Zhou, Zhe; Yildirim, Ali Ö; Bohla, Alexander; Rieber, Nikolaus; Kappler, Matthias; Koller, Barbara; Eber, Ernst; Eickmeier, Olaf; Zielen, Stefan; Eickelberg, Oliver; Griese, Matthias; Mall, Marcus A; Hartl, Dominik (2011). The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS ONE, 6(9), e24399. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0024399
Marcos, Veronica; Latzin, Phillip; Hector, Andreas; Sonanini, Sebastian; Hoffmann, Florian; Lacher, Martin; Koller, Barbara; Bufler, Philip; Nicolai, Thomas; Hartl, Dominik; Griese, Matthias (2010). Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases. Respiratory research, 11(1), p. 32. London: BioMed Central 10.1186/1465-9921-11-32
